Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

95.95
Delayed Data
As of Dec 08
 +1.71 / +1.81%
Today’s Change
59.09
Today|||52-Week Range
98.52
+53.23%
Year-to-Date

Today’s Trading

Previous close94.24
Today’s open94.62
Day’s range94.62 - 96.54
Volume5,296,985
Average volume (3 months)6,106,249
Market cap$153.0B
Dividend yield2.96%
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+15.21%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+12.16%
P/E ratio23.3
Price/Sales3.98
Price/Book32.96

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.05-0.12%
CELGCelgene+3.36+3.27%
GSKGlaxoSmithKline+0.33+0.95%
BMYBristol-Myers Squibb+0.58+0.94%
Data as of 4:02pm ET, 12/08/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$1.44
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts